AXXIS TECHNOLOGY GROUP LTD Inactive Instrument
Axxis Technology Group Ltd Stock Australian S.E.
Equities
AU0000AYGDC8
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
||
| - AUD | - |
|
| 05-17 | ECS Botanics Secures First B2C Medicinal Cannabis Contract | MT |
| 02-27 | ECS Botanics Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Sales 2022 | 7.18M 4.78M 6.53M | Sales 2023 | 15.39M 10.24M 14M | Capitalization | 27.67M 18.4M 25.18M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -665K -910K | Net income 2023 | - 0 0 | EV / Sales 2022 | 2.36 x |
| Net cash position 2022 | 1.85M 1.23M 1.68M | Net cash position 2023 | 2.21M 1.47M 2.01M | EV / Sales 2023 | 1.65 x |
| P/E ratio 2022 |
-15.5
x | P/E ratio 2023 |
-205
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.67% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 21-03-14 | |
Arthur Sun
DFI | Director of Finance/CFO | - | 21-04-30 |
Angela Macquire
COO | Chief Operating Officer | - | 21-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeremy King
CHM | Chairman | 50 | 17-01-10 |
| Chief Executive Officer | - | 21-03-14 | |
Michael Nitsche
BRD | Director/Board Member | - | 19-03-24 |
ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The Company utilizes progressive and cultivation methodologies to produce medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. The Company operates through two segments: ECS Botanics Pty Ltd (Botanics) and ECS Botanics MC Pty Ltd and Flowerday Farms Pty Ltd. Botanics is engaged in the sale of food and wellness products. ECS Botanics MC Pty Ltd and Flowerday Farms Pty Ltd are engaged in the sale of medicinal cannabis plant related products. It specializes in cultivating cannabis, which after drying and curing, is supplied as a trimmed flower for inhalation, or extracted into resin for further formulation or manufacturing. It cultivates a range of strains for extraction and inhalation. It also formulates a range of off the shelf and bespoke formulations to suite needs.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +23.05% | 254M | |
| +1.03% | 203M | |
| +26.74% | 158M | |
| +43.46% | 129M | |
| -14.29% | 121M | |
| +300.00% | 121M | |
| +71.19% | 99.12M | |
| -55.54% | 86.63M | |
| -15.38% | 83.53M |
